Ginkgo Bioworks Stock Options
| DNA Stock | USD 10.83 0.63 6.18% |
Ginkgo Bioworks' latest option contracts expiring on March 21st 2025 are carrying combined implied volatility of 1.22 with a put-to-call open interest ratio of 0.23 over 47 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on March 21st 2025. The total put volume is at 1.0, with calls trading at the volume of 348. This yields a 0.0 put-to-call volume ratio.
Open Interest Against March 21st 2025 Option Contracts
2025-03-21
The chart above shows Ginkgo Bioworks' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Ginkgo Bioworks' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Ginkgo Bioworks' option, there is no secondary market available for investors to trade.
Ginkgo Bioworks Maximum Pain Price Across 2025-03-21 Option Contracts
Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Ginkgo Bioworks close to expiration to expire worthless. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, Ginkgo Bioworks' option sellers may reap the most after selling more options than buying, causing them to expire worthless.
In The Money vs. Out of Money Option Contracts on Ginkgo Bioworks
Analyzing Ginkgo Bioworks' in-the-money options over time can help investors to take a profitable long position in Ginkgo Bioworks regardless of its overall volatility. This is especially true when Ginkgo Bioworks' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Ginkgo Bioworks' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Ginkgo Bioworks' stock while costing only a fraction of its price.
Ginkgo Bioworks' stock options are financial instruments that give investors the right to buy or sell shares of Ginkgo Bioworks Holdings common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Ginkgo stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Ginkgo Bioworks' stock price goes up or down, the stock options follow.
As of January 18, 2025, Total Stockholder Equity is expected to decline to about 1.2 B. In addition to that, Common Stock Shares Outstanding is expected to decline to about 41.6 MGinkgo Bioworks Holdings In The Money Call Balance
When Ginkgo Bioworks' strike price is surpassing the current stock price, the option contract against Ginkgo Bioworks Holdings stock is said to be in the money. When it comes to buying Ginkgo Bioworks' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Ginkgo Bioworks Holdings are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Ginkgo Current Options Market Mood
Ginkgo Bioworks' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Ginkgo Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of Ginkgo Bioworks' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Ginkgo Bioworks' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Ginkgo contract
Base on the Rule 16, the options market is currently suggesting that Ginkgo Bioworks Holdings will have an average daily up or down price movement of about 0.0763% per day over the life of the 2025-03-21 option contract. With Ginkgo Bioworks trading at USD 10.83, that is roughly USD 0.008258. If you think that the market is fully incorporating Ginkgo Bioworks' daily price movement you should consider buying Ginkgo Bioworks Holdings options at the current volatility level of 1.22%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Ginkgo |
Purchasing Ginkgo Bioworks options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Ginkgo calls. Remember, the seller must deliver Ginkgo Bioworks Holdings stock to the call owner when a call is exercised.
Ginkgo Bioworks Option Chain
When Ginkgo Bioworks' strike price is surpassing the current stock price, the option contract against Ginkgo Bioworks Holdings stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Ginkgo Bioworks' option chain is a display of a range of information that helps investors for ways to trade options on Ginkgo. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Ginkgo. It also shows strike prices and maturity days for a Ginkgo Bioworks against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | DNA1250321C00001000 | 15 | 1.0 | 0.0 - 0.2 | 0.2 | Out |
Call | DNA1250321C00000500 | 827 | 0.5 | 0.0 - 0.05 | 0.05 | Out |
Call | DNA250321C00001000 | 15 | 1.0 | 0.0 - 0.0 | 0.0 | Out |
Call | DNA250321C00000500 | 827 | 0.5 | 0.0 - 0.0 | 0.0 | Out |
Call | DNA250321C00002000 | 20 | 2.0 | 8.7 - 9.1 | 5.59 | In |
Call | DNA250321C00003000 | 11 | 3.0 | 7.7 - 8.8 | 5.08 | In |
Call | DNA250321C00004000 | 2 | 4.0 | 6.8 - 7.9 | 2.95 | In |
Call | DNA250321C00005000 | 45 | 5.0 | 5.9 - 6.3 | 5.2 | In |
Call | DNA250321C00006000 | 56 | 6.0 | 5.0 - 5.3 | 3.2 | In |
Call | DNA250321C00007000 | 87 | 7.0 | 4.2 - 5.0 | 3.47 | In |
Call | DNA250321C00008000 | 47 | 8.0 | 3.5 - 5.0 | 4.67 | In |
Call | DNA250321C00009000 | 85 | 9.0 | 2.75 - 3.4 | 1.9 | In |
Call | DNA250321C00010000 | 106 | 10.0 | 2.45 - 2.65 | 2.35 | In |
Call | DNA250321C00011000 | 952 | 11.0 | 2.0 - 2.3 | 2.0 | Out |
Call | DNA250321C00012000 | 140 | 12.0 | 1.65 - 1.75 | 1.74 | Out |
Call | DNA250321C00013000 | 160 | 13.0 | 1.35 - 2.5 | 1.43 | Out |
Call | DNA250321C00014000 | 84 | 14.0 | 1.1 - 2.3 | 1.0 | Out |
Call | DNA250321C00015000 | 617 | 15.0 | 0.9 - 1.05 | 1.02 | Out |
Call | DNA250321C00016000 | 19 | 16.0 | 0.75 - 0.9 | 0.6 | Out |
Call | DNA250321C00017000 | 2 | 17.0 | 0.6 - 1.8 | 0.68 | Out |
Call | DNA250321C00018000 | 18 | 18.0 | 0.45 - 0.65 | 0.33 | Out |
Call | DNA250321C00019000 | 2 | 19.0 | 0.35 - 0.55 | 0.59 | Out |
Call | DNA250321C00020000 | 0 | 20.0 | 0.3 - 0.5 | 0.16 | |
Call | DNA250321C00021000 | 12 | 21.0 | 0.25 - 0.45 | 0.21 | Out |
Call | DNA250321C00022000 | 0 | 22.0 | 0.2 - 0.35 | 0.2 | |
Call | DNA250321C00023000 | 4 | 23.0 | 0.15 - 0.35 | 0.1 | Out |
Put | DNA250321P00001000 | 5 | 1.0 | 0.0 - 0.0 | 0.0 | Out |
Put | DNA250321P00003000 | 29 | 3.0 | 0.0 - 0.75 | 0.25 | Out |
Put | DNA250321P00005000 | 53 | 5.0 | 0.05 - 0.2 | 0.25 | Out |
Put | DNA250321P00006000 | 156 | 6.0 | 0.1 - 0.35 | 0.55 | Out |
Put | DNA250321P00007000 | 415 | 7.0 | 0.25 - 0.55 | 0.9 | Out |
Put | DNA250321P00008000 | 119 | 8.0 | 0.7 - 0.85 | 0.95 | Out |
Put | DNA250321P00009000 | 60 | 9.0 | 1.1 - 1.25 | 1.24 | Out |
Put | DNA250321P00010000 | 37 | 10.0 | 1.6 - 1.65 | 1.5 | Out |
Put | DNA250321P00011000 | 51 | 11.0 | 2.15 - 2.3 | 3.01 | In |
Put | DNA250321P00012000 | 12 | 12.0 | 1.75 - 3.9 | 4.8 | In |
Put | DNA250321P00013000 | 25 | 13.0 | 2.1 - 4.5 | 5.5 | In |
Put | DNA250321P00014000 | 0 | 14.0 | 2.9 - 4.4 | 2.9 | In |
Put | DNA250321P00015000 | 3 | 15.0 | 3.6 - 5.2 | 5.9 | In |
Put | DNA250321P00016000 | 0 | 16.0 | 5.8 - 6.0 | 5.8 | In |
Put | DNA250321P00017000 | 0 | 17.0 | 6.6 - 6.9 | 6.6 | In |
Put | DNA250321P00018000 | 0 | 18.0 | 7.4 - 7.8 | 7.4 | In |
Put | DNA250321P00019000 | 0 | 19.0 | 8.3 - 8.7 | 8.3 | In |
Put | DNA250321P00020000 | 0 | 20.0 | 9.2 - 9.6 | 9.2 | In |
Put | DNA250321P00021000 | 0 | 21.0 | 10.1 - 10.6 | 10.1 | In |
Put | DNA250321P00022000 | 0 | 22.0 | 11.1 - 11.6 | 11.1 | In |
Put | DNA250321P00023000 | 0 | 23.0 | 12.1 - 12.5 | 12.1 | In |
Ginkgo Total Stockholder Equity
Total Stockholder Equity |
|
Ginkgo Bioworks Corporate Management
| Anna Wagner | Senior Development | Profile | |
| Samantha Sutton | Head People | Profile | |
| Joaquim Marques | Head Chemistry | Profile | |
| Mark Dmytruk | Chief Officer | Profile | |
| Reshma Shetty | President, Founder | Profile | |
| Joshua Dunn | Head Design | Profile | |
| Thomas Knight | Founder | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ginkgo Bioworks Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ginkgo Bioworks. If investors know Ginkgo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ginkgo Bioworks listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (12.89) | Revenue Per Share | Quarterly Revenue Growth 0.606 | Return On Assets | Return On Equity |
The market value of Ginkgo Bioworks Holdings is measured differently than its book value, which is the value of Ginkgo that is recorded on the company's balance sheet. Investors also form their own opinion of Ginkgo Bioworks' value that differs from its market value or its book value, called intrinsic value, which is Ginkgo Bioworks' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ginkgo Bioworks' market value can be influenced by many factors that don't directly affect Ginkgo Bioworks' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ginkgo Bioworks' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ginkgo Bioworks is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ginkgo Bioworks' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.